Navigation Links
Omnicell Announces Second Quarter 2009 Results
Date:7/23/2009

mparisons in their analysis of our performance.

Set forth below are additional reasons why share-based compensation expense related to SFAS No. 123R is excluded from our non-GAAP financial measures:

i) While share-based compensation calculated in accordance with SFAS No.123R constitutes an ongoing and recurring expense of Omnicell, it is not an expense that requires cash settlement by Omnicell. We therefore exclude these charges for purposes of evaluating core operating results. Thus, our non-GAAP measurements are presented exclusive of stock-based compensation expense to assist management and investors in evaluating our core operating results.

ii) We present SFAS No.123R share-based payment compensation expense in our reconciliation of non-GAAP financial measures on a pre-tax basis because the exact tax differences related to the timing and deductibility of share-based compensation, under SFAS No.123R, are dependent upon the trading price of Omnicell's common stock and the timing and exercise by employees of their stock options. As a result of these timing and market uncertainties the tax effect related to share-based compensation expense would be inconsistent in amount and frequency and is therefore excluded from our non-GAAP results.

As stated above, we present non-GAAP financial measures because we consider them to be important supplemental measures of performance. However, non-GAAP financial measures have limitations as an analytical tool and should not be considered in isolation or as a substitute for Omnicell's GAAP results. In the future, we expect to incur expenses similar to certain of the non-GAAP adjustments described above and expect to continue reporting non-GAAP financial measures excluding such items. Some of the limitations in relying on non-GAAP financial measures are:

-- Omnicell's stock option and stock purchase plans are important compo
'/>"/>

SOURCE Omnicell, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Omnicell to Release Second Quarter 2009 Earnings Results on July 23
2. Omnicell Improves Nursing Workflow with New Anywhere RN(TM) Remote Medication Management Application
3. Omnicell Boosts Pharmacy Efficiency with Enhanced WorkflowRx(TM) Central Pharmacy Automation Software
4. Omnicell Announces First Quarter 2009 Results
5. Omnicell to Release First Quarter 2009 Earnings Results on April 30
6. Omnicell Unveils Tissue Center Solution - Industrys First Integrated Tissue Tracking and Compliance System
7. Shands HealthCare Increases Operational Efficiency in Surgical Suites With Omnicell Supply Systems
8. Omnicell is Awarded Contract by Major National Academic Medical Center
9. Omnicell is Awarded Sole-source Contract by Emory Healthcare
10. Omnicell to Release Fourth Quarter 2008 Earnings Results on January 29
11. Omnicell Updates 2008 Year End Guidance and Announces Company Reorganization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many ... it on Facebook, Twitter, and Pinterest. The fans will have ... a lottery every week. , Moreover, the company has extended ... Angelweddingdress homepage for more information. , Angelweddingdress ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has ... View website of AngelWeddingDress.com to find more ... dresses online for a bridal party. AngelWeddingDress offers a ... them. Its maternity wedding dresses are specially designed for ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Juvent Sports ... at the 2015 PGA Merchandise Show to bestow a ... incredible female amateur golfer, Arlene McKitrick. The award commemorated ... amateur golf tournament win. She won her first amateur ...
(Date:1/22/2015)... January 22, 2015 Thousand of GranuFlo ... Care recalled its GranuFlo and NaturaLyte dialysis concentrates continue ... in U.S. District Court, District of Massachusetts, Bernstein Liebhard ... the Court has remanded a case filed by the ...
(Date:1/22/2015)... over 20 years, Dr. David Cruz of Cruz Chiropractic Care ... just about every type of injury that can result from car ... twenty-plus years, the team at Doctors on Liens has ... doctor. With the combined breadth of experience between the ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2
... have received grants from the California Institute for Regenerative ... treating diabetes and brain tumors. The intent of ... applications to the U.S. Food and Drug Administration within ... The two grants, awarded to collaborative scientific teams, total ...
... statins protect heart during infection , THURSDAY, Oct. 29 (HealthDay ... also help prevent death from severe flu, a new study ... evidence suggests that statins -- which include medicines such as ... infections. Whether they help with flu, however, has been more ...
... Oct. 29 Abbott (NYSE: ABT ) announced ... Improvement Award for environmental excellence. It is the ... efforts to safeguard the environment and integrate sustainability initiatives ... Illinois are an important part of our broader work ...
... WASHINGTON, Oct. 29 Bread for the World President Rev. ... Africa and Global Health to make ending hunger, child and ... an empowered, distinct development voice their top priorities. , ... this morning during a hearing in Congress. He said that ...
... therapies, which claim to use subtle energy to stimulate ... reducing the intensity of pain in a number of ... behaviors in dementia, over and above what standard treatments ... Shamini Jain, from the UCLA Division of Cancer Prevention ...
... 29 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ... of compounds for the treatment of cardiovascular and ... Senior Vice President Research & Development will present ... Disease", and will discuss the Company,s cardio-metabolic product ...
Cached Medicine News:Health News:UCSF diabetes, brain tumor stem cell grants to drive development of therapies 2Health News:UCSF diabetes, brain tumor stem cell grants to drive development of therapies 3Health News:UCSF diabetes, brain tumor stem cell grants to drive development of therapies 4Health News:Cholesterol Drugs May Help Prevent Flu Deaths 2Health News:Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois 2Health News:Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois 3Health News:Bread for the World Urges House Committee to Support U.S. Global Hunger Initiative 2Health News:Biofield therapies: Helpful or full of hype? 2Health News:VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 2Health News:VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 3Health News:VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 4Health News:VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 5
(Date:1/22/2015)... , Jan. 22, 2015  Bio-Techne Corporation (NASDAQ: ... the first member of the new Simple Plex platform ... This launch represents the re-branding of the previously acquired ... Plex platform is a transformative immunoassay technology which integrates ...
(Date:1/22/2015)... 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/3h534b/infectious ... Disease Diagnostics Market by Product, Application, Technology, End User ... offering. , The infectious disease diagnostics market ... reach $18,156.2 million by 2019 from $12,422.8 million in ...
(Date:1/22/2015)... Parenteral Drug Association (PDA) today announced the launch of its ... Future. The Manufacturing Science Program SM ... the ongoing focus PDA has on pharmaceutical and biopharmaceutical manufacturing. ... gaps in current manufacturing science as well as gaps that ...
Breaking Medicine Technology:Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3PDA Launches Manufacturing Science Program(SM) 2PDA Launches Manufacturing Science Program(SM) 3
... 14 Following an announcement from,Schering-Plough, Roche ... in combination with ribavirin as the market-leading,treatment ... United States and globally.,Despite clear biases in ... potentially,favored patients taking Peg-Intron(TM) (peginterferon alfa-2b) regimens ...
... Kibow Biotech, Inc. is pleased to,announce that ... Cooperation,Treaty (PCT) patent from Australia, China and ... and their Method of use for Gut-based,Therapy," ... Company,s oral,probiotic product formulation (Kibow Biotics(R)) which ...
Cached Medicine Technology:Roche responds to announcement of 'IDEAL' hepatitis C trial results 2Roche responds to announcement of 'IDEAL' hepatitis C trial results 3Roche responds to announcement of 'IDEAL' hepatitis C trial results 4Roche responds to announcement of 'IDEAL' hepatitis C trial results 5Roche responds to announcement of 'IDEAL' hepatitis C trial results 6Roche responds to announcement of 'IDEAL' hepatitis C trial results 7Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure 2Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: